A more extensive study with data from 10 patients with malignant insulinoma showed that somatostatin receptors type 2 were expressed in seven patients, whereas GLP-1R were present in four patients, and both receptors in only one patient (Wild et al., 2011). Here, SSTR2 is linked to pancreatic insulinoma.